US Patent Issued to SHANGHAI MEDICILON, MEDICILON PRECLINICAL RESEARCH (SHANGHAI) on Aug. 5 for "Pyrrolopyrazole derivatives, preparation method thereof and application thereof in medicine" (Chinese Inventors)

ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,378,252, issued on Aug. 5, was assigned to SHANGHAI MEDICILON INC. (Shanghai) and MEDICILON PRECLINICAL RESEARCH (SHANGHAI) LLC (Shanghai).

"Pyrrolopyrazole derivatives, preparation method thereof and application thereof in medicine" was invented by Feng Ren (Shanghai), Yongmei Xu (Shanghai), Xianlian Wang (Shanghai), Chunlin Chen (Shanghai) and Jinna Cai (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are a pyrrolopyrazole derivative, a preparation method therefor, and the medical use thereof. In particular, disclosed are a novel class of pyrrolopyrazole derivatives represented by general formula (I), a preparation method therefor, an...